Proxim Wireless Celebrates a Decade of Mobile Connectivity at Tranvía de Tenerife
Jun 12, 2017 12:00 pm UTC| Business
SILICON VALLEY, Calif., June 12, 2017 -- Proxim Wireless Corporation (OTC Markets:PRXM), a pioneer and global leader in point to point (PtP) and point to multipoint (PtMP) fixed and mobile wireless systems and advanced...
Ohr Pharmaceutical to Present at the 2017 Marcum Microcap Conference
Jun 12, 2017 12:00 pm UTC| Business
NEW YORK, June 12, 2017 -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that Jason Slakter, MD, Chief Executive...
Accellion Receives FedRAMP Authorization for its Secure Content Collaboration Platform
Jun 12, 2017 12:00 pm UTC| Business
PALO ALTO, Calif., June 12, 2017 -- Accellion, Inc.,the leading provider in hybrid and private cloud secure content collaboration, today announced it has received FedRAMP authorization from the U.S. Federal Government,...
TransUnion Appoints Suzanne P. Clark and Thomas L. Monahan to its Board of Directors
Jun 12, 2017 11:50 am UTC| Business
CHICAGO, June 12, 2017 -- TransUnion (NYSE:TRU) announced today that Suzanne P. Clark and Thomas L. “Tom” Monahan have been appointed to its Board of Directors. “Suzanne and Tom both bring strong depth in leadership...
Improved Laboratory Testing with EC4d Can Help Physicians Monitor Patients with Lupus
Jun 12, 2017 11:43 am UTC| Business
ALBUQUERQUE, NM and SAN DIEGO, CA, June 12, 2017 -- Exagen Diagnostics, Inc., home of AVISE® testing, announced the nationwide availability of a new test leveraging the power of cell-bound complement activation products...
IGC Acquires Exclusive Rights to THC-based treatment for Alzheimer’s Disease
Jun 12, 2017 11:36 am UTC| Business
BETHESDA, Md., June 12, 2017 -- India Globalization Capital, Inc. (NYSE MKT:IGC) is pleased to announce that it has entered into a definitive license agreement with the University of South Florida making IGC the...
Mateon Therapeutics Provides Update on its Clinical Trial Programs and Milestones
Jun 12, 2017 11:30 am UTC| Business
Interim Analyses for Key FOCUS Study Expected in August 2017 and September 2017Investigator-Sponsor Pauses Enrollment in PAZOFOS Study in U.K. SOUTH SAN FRANCISCO, Calif., June 12, 2017 -- Mateon Therapeutics, Inc....